Log­icBio guns for $75M IPO; Alexan­dria lands a new biotech build­ing on Long Is­land

→ Pro­lif­ic life-sci­ence de­vel­op­er Alexan­dria Re­al Es­tate Eq­ui­ties just plopped down $75M for a build­ing in Long Is­land City fresh off the heels of its pur­chase of Pfiz­er HQ in Man­hat­tan ear­li­er this year.

→ Cam­bridge-based Log­icBio is aim­ing for a $75 mil­lion haul dur­ing its IPO run. The gene edit­ing com­pa­ny is look­ing to beef up its cof­fers for a Phase I/II run on methyl­malonic acidemia (MMA). It will list un­der $LOGC on Nas­daq.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.